JANSSEN BIOTECH
Janssen Biotech, Inc. has delivered on the promise of new treatments and new ways to improve the health of individuals with serious disease. Built upon a rich legacy of innovative "firsts," Janssen Biotech, Inc. pursues innovative solutions in the therapeutic areas of immunology, oncology, and nephrology. With the same unwavering passion for new challenges, They dedicate ourselves to delivering solutions for these disease states where unmet needs continue to exist.
JANSSEN BIOTECH
Social Links:
Industry:
Biotechnology Health Care
Founded:
1979-01-01
Address:
Horsham, Pennsylvania, United States
Country:
United States
Website Url:
http://www.janssenbiotech.com
Total Employee:
10001+
Status:
Active
Contact:
2153254232
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Mobile Non Scaleable Content Euro
Similar Organizations
Geneius
Geneius is a Biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Michael Wall
Michael Wall Founder @ Janssen Biotech Founder 1979-01-01
Hilary Koprowski
Hilary Koprowski Founder @ Janssen Biotech Founder 1979-01-01
Carlo Croce
Carlo Croce Founder @ Janssen Biotech Founder
Hubert J.P. Schoemaker
Hubert J.P. Schoemaker Founder @ Janssen Biotech Founder
Vincent Zurawski
Vincent Zurawski Founder @ Janssen Biotech Founder
Founder
Carlo Croce
Hilary Koprowski
Hubert J.P. Schoemaker
Michael Wall
Vincent Zurawski
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2018-05-02 | BeneVir Biopharm | BeneVir Biopharm acquired by Janssen Biotech | N/A |
2008-01-01 | Centocor Ortho Biotech | Centocor Ortho Biotech acquired by Janssen Biotech | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-05-14 | Halozyme Therapeutics | Janssen Biotech investment in Post-IPO Equity - Halozyme Therapeutics | 15 M USD |
2013-07-15 | Amphivena Therapeutics | Janssen Biotech investment in Series A - Amphivena Therapeutics | 14 M USD |
Official Site Inspections
http://www.janssenbiotech.com Semrush global rank: 5.39 M Semrush visits lastest month: 1.56 K
- Host name: ec2-34-227-129-248.compute-1.amazonaws.com
- IP address: 34.227.129.248
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
Loading ...